Welcome to Risun Bio-Tech Inc!

Tel:+86-29-8610-0730
Categories
Contact Us

Tel:+86-29-8610-0730

Fax:+86-29-8610-5620

E-mail:sale@risunextract.com

Web:www.risunextract.com

News

Home > News > Content
Study Finds That Plant Extract Inhibots Hepatitis C
Risun Bio-Tech Inc | Updated: Oct 31, 2016

Study Finds That Plant Extract Inhibots Hepatitis C


  Researchers have discovered a possible new and inexpensive tool to fight hepatitis C virus (HCV) infection: quercetin, a natural 

flavonoid.


   The substance is sold as an herbal supplement and is found in many plans and foods, including red wine, onions, green tea, apples, 

and berries.


   A study describing research conducted by Angela Rojas of UCM Digestive Diseases, Virgen Macarena-Virgen del Rocio 

University Hospitals in Seville, Spain, and colleagues was published on the website Nature recently

 

   The researchers note that although direct-acting antivirals (DAAs) have improved the sustained viral response (SVR) rates 

dramatically, “price is still one of the major barriers to achieve hepatitis C eradication mainly in low- and middle-income countries.” 

Quercetin has been shown to inhibit diacylglycerol acyltransferase (DGAT) activity, which the researchers say is “an enzyme 

involved in the assembly step of the HCV life cycle.” 

 

   Additionally, quercetin “is widely available, cheap, and has been previously demonstrated antiviral activity against HCV,” say the 

researchers, adding, “The main aims of this study were to further elucidate at which steps of the virus life cycle and by which 

mechanisms quercetin exerts anti-HCV activity.” 

 

   The researchers identified several points in the HCV life cycle at which quercetin had an effect. They say, “it i) inhibits HCV 

genome replication; ii) affects the morphogenesis of infectious particles, thus decreasing HCV specific infectivity; iii) affects the virion

 integrity when applied directly onto HCV particles; and iv) hampers the localization of HCV core proteins to LDs [lipid droplets].” 

Additionally, a phase I clinical trial has demonstrated that high doses of quercetin are well-tolerated. 

 

   In addition to finding that quercetin interrupts the life cycle of HCV, the researchers say they found that it “hijacks the host lipid 

metabolism to fulfill its life cycle from assembly to replication steps,” and that it “pre-empts the subcellular localization of core protein

 to LDs,” and finally, “is able to decrease HCV infectivity by at least two distinct mechanisms.” 

 

“In conclusion, we showed that quercetin targets both viral and host factors, and hence interferes with HCV infectious cycle at 

different steps,” say the authors.